Hence, in this study, we aimed to determine whether deletion of either Spry 1 or Spry 2 alone could induce neoplastic changes in the mouse prostate, whilst also assessing public gene expression datasets to test the hypothesis that cosuppression of SPRYs and SPREDs is associated with aggressive prostate cancers. The gene discussed is SPRY1; the disease is prostate carcinoma.